• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

随着成纤维细胞生长因子-2(FGF-2)的扩增,人骨髓间充质基质细胞的软骨形成潜力呈年龄依赖性下降。

Age-dependent decrease in the chondrogenic potential of human bone marrow mesenchymal stromal cells expanded with fibroblast growth factor-2.

机构信息

Natural Science Center for Basic Research and Development, Hiroshima University, Hiroshima, Japan.

出版信息

Cytotherapy. 2013 Sep;15(9):1062-72. doi: 10.1016/j.jcyt.2013.03.015. Epub 2013 Jun 22.

DOI:10.1016/j.jcyt.2013.03.015
PMID:23800732
Abstract

BACKGROUND AIMS

Human bone marrow mesenchymal stromal cells are useful in regenerative medicine for various diseases, but it remains unclear whether the aging of donors alters the multipotency of these cells. In this study, we examined age-related changes in the chondrogenic, osteogenic and adipogenic potential of mesenchymal stromal cells from 17 donors (25-81 years old), including patients with or without systemic vascular diseases.

METHODS

All stem cell lines were expanded with fibroblast growth factor-2 and then exposed to differentiation induction media. The chondrogenic potential was determined from the glycosaminoglycan content and the SOX9, collagen type 2 alpha 1 (COL2A1) and aggrecan (AGG) messenger RNA levels. The osteogenic potential was determined by monitoring the alkaline phosphatase activity and calcium content, and the adipogenic potential was determined from the glycerol-3-phosphate dehydrogenase activity and oil red O staining.

RESULTS

Systemic vascular diseases, including arteriosclerosis obliterans and Buerger disease, did not significantly affect the trilineage differentiation potential of the cells. Under these conditions, all chondrocyte markers examined, including the SOX9 messenger RNA level, showed age-related decline, whereas none of the osteoblast or adipocyte markers showed age-dependent changes.

CONCLUSIONS

The aging of donors from young adult to elderly selectively decreased the chondrogenic potential of mesenchymal stromal cells. This information will be useful in stromal cell-based therapy for cartilage-related diseases.

摘要

背景目的

人类骨髓间充质基质细胞在各种疾病的再生医学中具有重要作用,但供体的衰老是否改变这些细胞的多能性仍不清楚。在这项研究中,我们检查了来自 17 名供体(25-81 岁)的间充质基质细胞的软骨形成、成骨和脂肪形成潜能的年龄相关变化,包括患有或不患有系统性血管疾病的患者。

方法

所有干细胞系均用成纤维细胞生长因子-2 扩增,然后暴露于分化诱导培养基中。通过测定糖胺聚糖含量以及 SOX9、胶原类型 2 阿尔法 1(COL2A1)和聚集蛋白(AGG)信使 RNA 水平来确定软骨形成潜能。通过监测碱性磷酸酶活性和钙含量来确定成骨潜能,通过甘油-3-磷酸脱氢酶活性和油红 O 染色来确定脂肪形成潜能。

结果

包括动脉硬化闭塞症和伯格病在内的系统性血管疾病并没有显著影响细胞的三系分化潜能。在这些条件下,所有检查的软骨细胞标志物,包括 SOX9 信使 RNA 水平,均表现出与年龄相关的下降,而没有任何成骨细胞或脂肪细胞标志物表现出与年龄相关的变化。

结论

从年轻成年到老年的供体衰老选择性地降低了间充质基质细胞的软骨形成潜能。这些信息将对基于基质细胞的软骨相关疾病治疗有用。

相似文献

1
Age-dependent decrease in the chondrogenic potential of human bone marrow mesenchymal stromal cells expanded with fibroblast growth factor-2.随着成纤维细胞生长因子-2(FGF-2)的扩增,人骨髓间充质基质细胞的软骨形成潜力呈年龄依赖性下降。
Cytotherapy. 2013 Sep;15(9):1062-72. doi: 10.1016/j.jcyt.2013.03.015. Epub 2013 Jun 22.
2
The role of BMP-7 in chondrogenic and osteogenic differentiation of human bone marrow multipotent mesenchymal stromal cells in vitro.BMP-7 在人骨髓间充质基质细胞体外成软骨和成骨分化中的作用。
J Cell Biochem. 2010 Feb 1;109(2):406-16. doi: 10.1002/jcb.22412.
3
Isolation and multilineage differentiation of bone marrow mesenchymal stem cells from abattoir-derived bovine fetuses.来自屠宰场牛胎儿的骨髓间充质干细胞的分离及多向分化
BMC Vet Res. 2013 Jul 5;9:133. doi: 10.1186/1746-6148-9-133.
4
Bone marrow concentrated cell transplantation: rationale for its use in the treatment of human osteochondral lesions.骨髓浓缩细胞移植:在人类骨软骨病变治疗中应用的原理。
J Biol Regul Homeost Agents. 2013 Jan-Mar;27(1):165-75.
5
Contribution of the Interleukin-6/STAT-3 Signaling Pathway to Chondrogenic Differentiation of Human Mesenchymal Stem Cells.白细胞介素-6/STAT3 信号通路对人骨髓间充质干细胞向软骨分化的作用。
Arthritis Rheumatol. 2015 May;67(5):1250-60. doi: 10.1002/art.39036.
6
Chondrogenic differentiation of bone marrow-derived mesenchymal stromal cells via biomimetic and bioactive poly-ε-caprolactone scaffolds.仿生和生物活性聚己内酯支架诱导骨髓间充质基质细胞的软骨分化。
J Biomed Mater Res A. 2013 Jun;101(6):1620-8. doi: 10.1002/jbm.a.34457. Epub 2012 Nov 27.
7
Isolation and prolonged expansion of oral mesenchymal stem cells under clinical-grade, GMP-compliant conditions differentially affects "stemness" properties.在临床级、GMP 合规条件下分离和长期扩增口腔间充质干细胞会对“干性”特性产生差异影响。
Stem Cell Res Ther. 2017 Nov 2;8(1):247. doi: 10.1186/s13287-017-0705-0.
8
CaMKII plays a part in the chondrogenesis of bone marrow-derived mesenchymal stem cells.钙调蛋白激酶II在骨髓间充质干细胞的软骨形成过程中发挥作用。
Int J Clin Exp Pathol. 2015 May 1;8(5):5981-7. eCollection 2015.
9
Isolation and multilineage differentiation of bovine bone marrow mesenchymal stem cells.牛骨髓间充质干细胞的分离与多向分化
Cell Tissue Res. 2005 Feb;319(2):243-53. doi: 10.1007/s00441-004-1012-5. Epub 2004 Nov 20.
10
Selection of highly osteogenic and chondrogenic cells from bone marrow stromal cells in biocompatible polymer-coated plates.从生物相容性聚合物涂层板中的骨髓基质细胞中选择具有高成骨和成软骨特性的细胞。
J Biomed Mater Res A. 2010 Mar 15;92(4):1273-82. doi: 10.1002/jbm.a.32460.

引用本文的文献

1
Identification of critical process parameters and quality attributes for bioreactor-based expansion of human MSCs.确定基于生物反应器的人骨髓间充质干细胞扩增的关键工艺参数和质量属性。
Front Bioeng Biotechnol. 2025 Aug 21;13:1608194. doi: 10.3389/fbioe.2025.1608194. eCollection 2025.
2
Requirements for standardizing the assessment of mesenchymal stem cell therapy and its effects on osteoarthritis.间充质干细胞治疗骨关节炎评估标准化的要求及其效果
World J Orthop. 2025 Mar 18;16(3):104451. doi: 10.5312/wjo.v16.i3.104451.
3
Prolonged cultivation enhances the stimulatory activity of hiPSC mesenchymal progenitor-derived conditioned medium.
长期培养增强 hiPSC 间质祖细胞衍生条件培养基的刺激活性。
Stem Cell Res Ther. 2024 Nov 17;15(1):434. doi: 10.1186/s13287-024-03960-5.
4
Reduced Cell Migration in Human Chondrocyte Sheets Increases Tissue Stiffness and Cartilage Protein Production.人软骨细胞片层中细胞迁移减少会增加组织硬度和软骨蛋白的产生。
Tissue Eng Regen Med. 2024 Oct;21(7):1021-1036. doi: 10.1007/s13770-024-00662-0. Epub 2024 Jul 22.
5
Possibilities and efficiency of MSC co-transfection for gene therapy.间充质干细胞共转染在基因治疗中的可能性和效率。
Stem Cell Res Ther. 2024 May 23;15(1):150. doi: 10.1186/s13287-024-03757-6.
6
Mesenchymal Stromal Cells: Heterogeneity and Therapeutical Applications.间质基质细胞:异质性与治疗应用。
Cells. 2023 Aug 10;12(16):2039. doi: 10.3390/cells12162039.
7
Aged mesenchymal stem cells and inflammation: from pathology to potential therapeutic strategies.衰老间充质干细胞与炎症:从病理机制到潜在治疗策略。
Biol Direct. 2023 Jul 18;18(1):40. doi: 10.1186/s13062-023-00394-6.
8
Awakening of Dormant Breast Cancer Cells in the Bone Marrow.骨髓中休眠乳腺癌细胞的苏醒
Cancers (Basel). 2023 Jun 1;15(11):3021. doi: 10.3390/cancers15113021.
9
Impact of Environmental and Epigenetic Changes on Mesenchymal Stem Cells during Aging.环境和表观遗传变化对衰老过程中间充质干细胞的影响。
Int J Mol Sci. 2023 Mar 30;24(7):6499. doi: 10.3390/ijms24076499.
10
Managing the Heterogeneity of Mesenchymal Stem Cells for Cartilage Regenerative Therapy: A Review.用于软骨再生治疗的间充质干细胞异质性管理:综述
Bioengineering (Basel). 2023 Mar 13;10(3):355. doi: 10.3390/bioengineering10030355.